We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

170 hedge funds and large institutions have $499M invested in ANI Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 65 increasing their positions, 59 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more call options, than puts

Call options by funds: $3.63M | Put options by funds: $2.6M

10% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 59

8.53% less ownership

Funds ownership: 75.52% → 67% (-8.5%)

11% less funds holding

Funds holding: 190 → 170 (-20)

25% less capital invested

Capital invested by funds: $664M → $499M (-$165M)

46% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 28

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
170
Holders Change
-20
Holders Change %
-10.53%
% of All Funds
3.35%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
65
Reduced
59
Closed
28
Calls
$3.63M
Puts
$2.6M
Net Calls
+$1.03M
Net Calls Change
+$2.67M

Top Buyers

1
Invesco
Invesco
Georgia
+$10.8M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$8.1M
3
Goldman Sachs
Goldman Sachs
New York
+$3.55M
4
QI
QS Investors
New York
+$2.31M
5
HRCM
Hawk Ridge Capital Management
California
+$2.24M

Top Sellers

1
Nomura Holdings
Nomura Holdings
Japan
-$29.4M
2
Deutsche Bank
Deutsche Bank
Germany
-$19.8M
3
MP
Mangrove Partners
Connecticut
-$12.1M
4
CCM
Consonance Capital Management
New York
-$10.4M
5
Citigroup
Citigroup
New York
-$5.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
LSV Asset Management
26
LSV Asset Management
Illinois
$4.43M -$1.54M -23,300 -24%
N
27
Nuveen
North Carolina
$3.81M -$335K -5,056 -8%
Ameriprise
28
Ameriprise
Minnesota
$3.4M -$154K -2,331 -4%
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$3.12M +$2.05M +30,897 +157%
Morgan Stanley
30
Morgan Stanley
New York
$2.86M +$912K +13,761 +42%
RIM
31
Regent Investment Management
Kentucky
$2.55M +$111K +1,670 +4%
MAM
32
Martingale Asset Management
Massachusetts
$2.48M -$358K -5,400 -12%
GC
33
Globeflex Capital
California
$2.4M +$605K +9,126 +31%
SCP
34
Seizert Capital Partners
Michigan
$2.34M -$73.8K -1,114 -3%
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$2.28M +$183K +2,756 +8%
HSA
36
Hussman Strategic Advisors
Maryland
$2.19M – – –
CCM
37
Cadence Capital Management
Massachusetts
$2.12M -$375K -5,655 -14%
QI
38
QS Investors
New York
$2.1M +$2.31M +34,900 New
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$1.91M +$147K +2,217 +8%
RHJA
40
Rice Hall James & Associates
California
$1.72M -$46.8K -706 -2%
Acadian Asset Management
41
Acadian Asset Management
Massachusetts
$1.72M +$1.52M +22,954 +468%
DIA
42
Dana Investment Advisors
Wisconsin
$1.63M +$128K +1,927 +8%
PPA
43
Parametric Portfolio Associates
Washington
$1.61M -$277K -4,185 -14%
New York State Teachers Retirement System (NYSTRS)
44
New York State Teachers Retirement System (NYSTRS)
New York
$1.56M +$6.62K +100 +0.4%
Allianz Asset Management
45
Allianz Asset Management
Germany
$1.56M +$28.9K +436 +2%
1CM
46
1492 Capital Management
Wisconsin
$1.55M -$5.83K -88 -0.3%
State Board of Administration of Florida Retirement System
47
State Board of Administration of Florida Retirement System
Florida
$1.49M – – –
Legal & General Group
48
Legal & General Group
United Kingdom
$1.46M +$119K +1,790 +8%
First Trust Advisors
49
First Trust Advisors
Illinois
$1.39M +$1.5M +22,584 New
Bessemer Group
50
Bessemer Group
New Jersey
$1.38M -$99.4K -1,500 -6%
1
2
3 4 5

ANIP Hedge Fund Activity: Q4 2019 in Review

170 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q4 2019, worth a combined $499M — down 25% from $664M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of ANIP and 15 opened new positions — a net loss of 13 holders — while 59 trimmed existing stakes and 65 added.

The largest buyer was Invesco, adding an estimated $10.8M. The largest seller was Nomura Holdings, exiting entirely with an estimated $29.4M sold.

  • 170 institutional investors held ANI Pharmaceuticals (ANIP) as of Q4 2019, down from 190 in Q3 2019.
  • Funds reported $499M of ANI Pharmaceuticals stock for Q4 2019, down 25% quarter-over-quarter.
  • 15 funds opened new ANI Pharmaceuticals positions in Q4 2019 and 28 closed out, a net change of -13 holders.
  • The largest ANI Pharmaceuticals buyer in Q4 2019 was Invesco, an estimated $10.8M added.
  • The largest ANI Pharmaceuticals seller in Q4 2019 was Nomura Holdings, an estimated $29.4M sold.

Based on aggregated 13F filings for Q4 2019.